Sandostatin - octreotide acetate
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0183 |
| Proprietary Name: | Sandostatin |
| Suffix: | |
| Non-Proprietary Name: | octreotide acetate |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS; SUBCUTANEOUS |
| Original Marketing Date: | 21-10-1998 |
| Category Name: | NDA |
| Application Number: | NDA019667 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | OCTREOTIDE ACETATE |
| Active Numerator Strength: | 200 |
| Active Ingredient Unit: | ug/mL |
| Pharm Classes: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
| DEA Schedule: |